Place of cardioprotective metabolic therapy in patients with arterial hypertension and ischemic heart disease

Author: Oksana Leonidovna Rekovets, Candidate of Medical Sciences, Senior Researcher, Department of Symptomatic Hypertension

State Institution «NSC «Institute of Cardiology. M. D. Strazhesko «NAMS of Ukraine» (Kyiv)


On April 6, the scientific-practical conference «Heart and blood vessels» was held, at which the most important aspects of managing patients with a cardiovascular profile were considered. Report of the Senior Researcher of the Department of Symptomatic Hypertension of the State Institution NSC Institute of Cardiology named after N.N. N. D. Strazhesko of the National Academy of Medical Sciences of Ukraine (Kyiv), Candidate of Medical Sciences Oksana Leonidovna Rekovets, touched upon the place of cardioprotective metabolic therapy in patients with arterial hypertension (AH) and coronary heart disease (CHD).

ARTICLES FROM CATEGORY
Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"

PROVE YOU ARE A MEDICAL PROFESSIONAL

Attention: This section is intended for healthcare professionals only. If you are not a medical professional, you can return to the main page by clicking the “No” option

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design